Prevalence of High Grade Squamous Intraepithelial Lesions (HSIL) and invasive cervical cancer in patients with atypical squamous cells of undetermined significance (ASCUS) from cervical PAP smears

Southeast Asian Journal of Tropical Medicine and Public Health

Volumn 39, Issue 4, 2008, Pages 737-744

  Limpvanuspong, Benchawan ^a   Tangjitgamol, Siriwan ^a   Manusirivithaya, Sumonmal ^a   Khunnarong, Jakkapan ^a   Thavaramara, Thaovalai ^a   Leelahakorn, Surawute ^a  

^a NAVAMINDRADHIRAJ UNIVERSITY   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 49749097138     PISSN: 01251562     EISSN: 26975718     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Abu-Jawdeh GM, Wang HH. Histologic study of squamous atypia on Pap smears [Abstract]. Mod Pathol 1994; 7: 33A.
2. Auger M, Charbonneau M, Arseneau J. Atypical squamous cells of undetermined significance. A cytohistologic study of 52 cases. Acta Cytol 1997; 41: 1671-5.
3. Davey D, Woodhouse S, Styer P, Stastny J, Mody D. Atypical epithelial cells and specimen adequacy: current laboratory practices of participants in the College of American Pathologists interlaboratory comparison program in cervicovaginal cytology. Arch Pathol Lab Med 2000; 124: 203-11.
4. Dvorak KA, Finnemore M, Maksem JA. Histology correlation with atypical squamous cells of undetermined significance (ASCUS) and low grade squamous intraepithelial lesion (LSIL) cytology diagnoses: An argument to ensure ASCUS follow up that is an aggressive as that for LSIL. Cytopathology 1999; 21: 292-5.
5. Ergenneli MH, Duran EH, Ergin T, Demirthan B, Erdogan M. Atyical squamous cells of undetermined significance. Clinical experience in a Turkish University Hospital. Eur J Obstet Gynecol Reprod Biol 2001; 96: 108-10.
6. Ghaemmaghami F, Ensani F, Behtash N, Nejad EH. Pap smear with atypical squamous cells of undetermined significance. Arch Irn Med 2005; 8: 192-6.
7. Holcomb K, Abulafia O, Matthews RP, et al. The significance of ASCUS cytology in HIV-positive women. Gynecol Oncol 1999; 75: 118-21.
8. Kim JJ, Wright JC, Goldie SJ. Cost effectiveness of alternative triage strategies for atypical squamous cells of undetermined significance. JAMA 2002; 287: 2382-90.
9. Kinney WK, Manos MM, Hurley LB, Ransley JE. Where's the high-grade cervical neoplasia? The importance of minimally abnormal Papanicolaou diagnoses. Obstet Gynecol 1998; 91: 973-6.
10. Lachman MF, Cavallo-Calvanese C. Qualification of atypical squamous cells of undetermined significance in an independent laboratory: is it useful or significant? Am J Obstet Gynecol 1998; 179: 421-9.
11. Lindheim SF, Smith-Nguyen G. Aggressive evaluation for atypical squamous cells in Papanicoloau smears. J Reprod Med 1990; 35: 971-3.
12. Lousuebsakul V, Knutsen SM, Gram IT, Akin MR. Clinical impact of atypical squamous cells of undetermined significance. A cytohistologic comparison. Acta Cytol 2000; 44: 23-30.
13. Massad LS, Behbakht K, Collins YC, Cejtin HE. Histologic findings from the cervix among older women with abnormal cervical cytology. Gynecol Oncol 2003; 88: 340-4.
14. Massad LS, Collins YC, Meyer PM. Biopsy correlates of abnormal cervical cytology classified using the Bethesda System. Gynecol Oncol 2001; 82: 516-22.
15. Mood Nl, Haratian A. Atypical squamous cells of undetermined significance: A cytohistologic study. Acta Med Irn 2004; 42: 295-9.
16. National Cancer Institute Workshop. The 1988 Bethesda system for reporting cervical/vaginal cytological diagnoses. JAMA 1989; 262: 931-4.
17. National Cancer Institute Workshop. The Bethesda system for reporting cervical/vaginal cytologic diagnoses: revised after second National Cancer Institute Workshop (April 29-30, 1991). Acta Cytol 1993; 37: 115-24.
18. Papanicolaou G, Traut RF. The diagnosis of uterine cancer by vaginal smear. New York: Commonwealth Fund, 1943.
19. Parkin MD, Bray F, Ferlay J, Pisani P. Globocan statistics, 2002. CA Cancer J Clin 2002; 55: 74-108.
20. Saslow D, Runowicz C, Solomon D, et al. American Cancer Society cervical cancer screening guidelines 2002. CA Cancer J Clin 2002; 52: 375-6.
21. st Century: An International Expert Conference and Tutorial. Acta Cytol 1998; 42: 16-24.
22. Srivatanakul P, Deerasamee S, Parkin M. Introduction. In: Deerasamee S, Martin N, Sontipong S, et al., eds. Cancer in Thailand. Vol II, 1992-1994. Lyon: IARC, 1999: 17-25.
23. Staler MH. New Bethesda terminology and evidence-based management guidelines for cervical pathology findings. JAMA 2002; 287: 2140-1.
24. Staler MH, Schiffman M. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage study. JAMA 2001; 285: 1500-5.
25. Williams ML, Rimm DL, Pedigo MA, Frable WJ. Atypical squamous cells of undetermined significance: correlative histologic and follow-up studies from an academic medical center. Diagn Cytopathol 1997; 16: 1-7.
26. Wright TC Jr, Cox JT, Massad LS, Twiggs LB, Wilkinson EJ. 2001 consensus guidelines for the management of women with cervical cytological abnormalities. JAMA 2002; 287: 2120-9.